Annual report with a comprehensive overview of the company - Form 10-K

IR Nav

SEC Filing For null
 AXIM BIOTECHNOLOGIES, INC. - 10-K (Filed: 15-03-2018) Close Window
Sub Document 1
Page 5: PART I
Page 9: PART II
Page 11: Going Concern
Page 15: PART III
Page 22: (cont'd)
Page 26: (cont'd)
Page 27: SIGNATURES
Page 28: (cont'd)
Page 30: (cont'd)
Page 31: (cont'd)
Page 33: (cont'd)
Page 43: (cont'd)
Page 46: (cont'd)
Page 47: (cont'd)
Page 49: Litigation
Sub Document 2
Sub Document 3
Sub Document 4
Sub Document 5
Sub Document 6
Sub Document 7
Sub Document 8
Sub Document 9
Sub Document 10
Sub Document 11
Sub Document 12
Sub Document 13

Copyright © 2018 QuoteMedia. All rights reserved. Terms of Use.
Market Data powered by QuoteMedia, www.quotemedia.com, SEC filings by Morningstar.